儿童癌症幸存者的早发性卵巢功能不全:来自圣犹达终身队列的报告
该横断面研究纳入921名儿童癌症幸存者(中位年龄31.7岁,诊断后中位24.0年),早发性卵巢功能不全(POI)患病率为10.9%。任何剂量的卵巢放疗和环磷酰胺当量剂量≥8000 mg/m2是POI的独立危险因素,POI与低骨密度和衰弱独立相关。作者认为高危患者应尽可能提供生育力保护,并需进一步研究性激素替代治疗的作用。
要点
- 儿童癌症幸存者中POI患病率为10.9%。
- 任何剂量卵巢放疗和环磷酰胺当量剂量≥8000 mg/m2是POI独立危险因素。
- POI与低骨密度和衰弱独立相关,作者建议高危者尽可能提供生育力保护。
核心结论
- 大剂量烷化剂和任何剂量的卵巢放疗与POI相关,最高危患者应尽可能提供生育力保护。
- POI导致儿童癌症幸存者总体健康结局不良,需进一步研究性激素替代治疗在改善这些结局中的作用。
研究设计与样本
- 圣犹达终身队列研究(St. Jude Lifetime Cohort Study)的横断面研究,在三级医疗中心开展。
- 共评估921名参与者,中位年龄31.7岁,癌症诊断后中位24.0年接受评估。
主要发现
- POI患病率为10.9%。
- POI的独立危险因素包括任何剂量的卵巢放疗和环磷酰胺当量剂量(CED)≥8000 mg/m2。
- 在圣犹达终身队列评估时体重指数≥30 kg/m2的患者诊断POI的可能性较低。
- 低骨密度和衰弱与POI独立相关。
关键数值与推荐
- POI定义为40岁前持续闭经合并卵泡刺激素水平>30 IU/L。
- 烷化剂暴露采用经验证的环磷酰胺当量剂量(CED)进行量化。
临床怎么用
- 作者认为最高危患者应尽可能提供生育力保护。
- 作者认为需进一步研究性激素替代治疗在改善POI相关不良健康结局中的作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Long-term follow-up data on premature ovarian insufficiency (POI) in childhood cancer survivors are limited. OBJECTIVE: To describe the prevalence of POI, its risk factors, and associated long-term adverse health outcomes. DESIGN: Cross-sectional. SETTING: The St. Jude Lifetime Cohort Study, an established cohort in a tertiary care center. PATIENTS: Nine hundred twenty-one participants (median age, 31.7 years) were evaluated at a median of 24.0 years after cancer diagnosis. MAIN OUTCOME MEASURE: POI was defined by persistent amenorrhea combined with a follicle-stimulating hormone level >30 IU/L before age 40. Multivariable Cox regression was used to study associations between demographic or treatment-related risk factors and POI. Multivariable logistic regression was used to study associations between POI and markers for cardiovascular disease, bone mineral density (BMD), and frailty. Exposure to alkylating agents was quantified using the validated cyclophosphamide equivalent dose (CED). RESULTS: The prevalence of POI was 10.9%. Independent risk factors for POI included ovarian radiotherapy at any dose and CED ≥8000 mg/m2. Patients with a body mass index ≥30 kg/m2 at the time of the St. Jude Lifetime Cohort assessment were less likely to have a diagnosis of POI. Low BMD and frailty were independently associated with POI. CONCLUSION: High-dose alkylating agents and ovarian radiotherapy at any dose are associated with POI. Patients at the highest risk should be offered fertility preservation whenever feasible. POI contributes to poor general health outcomes in childhood cancer survivors; further studies are needed to investigate the role of sex hormone replacement in improving such outcomes.
引用
- Chemaitilly W, Li Z, Krasin MJ, et al. Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort. J Clin Endocrinol Metab. 2017. PMID: 28368472. doi:10.1210/jc.2016-3723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。